Annual & Interim Reports
Interim Report 2008
30 June 2008
Report & Accounts for Year Ended 31 December 2007
20 June 2008
Annual Report 2006
2 July 2007
FuturaGene announces the details of its issued share capital and voting rights
27 December 2006
FuturaGene Acquires CBD Technologies
20 December 2006
Grant of Options to Directors 
28 November 2006
FuturaGene Announces the Acquisition of CBD Technologies
24 November 2006
Interim Financial Results 2006
29 September 2006
FuturaGene Announces AGM Result
19 July 2006
Directorate Change
27 June 2006
Annual Report 2005
26 June 2006
FuturaGene Announces Appointment of New Board Member
26 June 2006
FuturaGene Granted 10-Year Business Licence in China
21 January 2006
Directorate Change
18 January 2006
Clarification RE Change of Adviser
03 October 2005
Interim Financial Results 2005
30 September 2005
FuturaGene Announces The Appointment of Kannan Grant as Executive Director with Responsibility for Licensing Joint Ventures
06 July 2005
Annual Report 2004
30 June 2005
FuturaGene Licence for Osmotin Offers Possible Breakthrough Treatments For Obesity, Heart Disease and Diabetes
09 May 2005
FuturaGene Plans Chinese Joint Venture
29 March 2005
FuturaGene Announces The Appointment of David Malsbary As Non-Executive Director
05 January 2005
Interim Financial Results 2004
30 September 2004
FuturaGene Announces The Appointment of Kannan Grant as Non-Executive Director
22 September 2004
OverNet Data PLC Announces Approval of Acquisition and Name Change
14 June 2004